China post-marketing surveillance (PMS) study of Fabrazyme®

Trial Identifier: LPS16583
Sponsor: Genzyme, a Sanofi Company
Start Date: October 2021
Primary Completion Date: March 2023
Study Completion Date: March 2023
Condition: Fabry's Disease

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description

Trial Locations

Country Location
China Beijing, China, 100730
China Beijing, China, 100034
China Shanghai, China, 201102
China Shanghai, China, 200025
China Taiyuan, China, 030001
China Wuhan Shi, China, 016040